#United States #Houston #Artificial Intelligence #Hematologic Oncology #SOHO 2025

The 13th Annual Meeting of the Society of Hematologic Oncology

The Society of Hematologic Oncology (SOHO) has officially opened registration for its 13th Annual Meeting, scheduled for September 3-6, 2025, in Houston, Texas. This esteemed event aims to gather leading experts from around the globe to discuss the latest advancements and challenges in hematologic oncology, with particular emphasis on how artificial intelligence (AI) is transforming the field.

A Glimpse into the Event

Under the theme of 2025 A Hematology Odyssey – Unleashing AI, Genomics, Targets, and Immune Engineering, this year's meeting will delve into innovative strategies and technologies that are reshaping our understanding, diagnosis, and treatment of hematologic malignancies. The theme was selected by Dr. Phillip Scheinberg, SOHO President and chief of hematology at the Hospital A Beneficência Portuguesa de São Paulo, Brazil. He noted that these emerging frontiers are revolutionizing the care landscape, making way for unprecedented possibilities in patient outcomes.

At SOHO 2025, attendees can expect a rich program of keynote lectures, panel discussions, and abstract presentations. Networking opportunities allow participants to engage with fellow experts and thought leaders, fostering collaboration and sharing of insights.

Keynote Speakers

The event will feature remarkable plenary talks from distinguished experts, including:

• - Sagar Lonial, MD, FACP (Emory University Winship Cancer Institute) on September 3
• - Jennifer R. Brown, MD, PhD (Dana-Farber Cancer Institute) on September 4
• - A third speaker to be announced for September 5

Early Registration Benefits

Professionals are encouraged to register early, as those who sign up before June 8, 2025, will benefit from a special early bird discount. Members of SOHO can enjoy an additional 40% discount on their registration fees. Joining SOHO is free, presenting an excellent opportunity for professionals in the field to save significantly while connecting with peers.

Anyone interested in sponsorship opportunities for SOHO 2025 can visit soho.click/sponsors or reach out to Belinda Melder at [email protected] to explore participation in discussions surrounding significant advancements in hematologic malignancies.

Staying Updated with SOHO

Stay informed about the upcoming meeting and other SOHO activities through the SOHO Insider, the society's premier news source, available in both print and online formats. Following SOHO on social media is also a great way to keep up with the latest updates.

About SOHO

Founded in 2012, the Society of Hematologic Oncology is a nonprofit organization dedicated to promoting global research, education, and optimal patient care in hematologic malignancies. Its mission encompasses advancing worldwide understanding through the exchange of scientific information, helping foster better treatment methodologies and care strategies.

As of now, SOHO has nearly 10,000 members across 120 countries, unequivocally establishing its commitment to addressing critical topics within hematology.

Join your peers from around the world at SOHO 2025 and take part in defining the future of hematologic oncology, explore the impact of AI in research, and gain valuable insights from field experts.